SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 15th, 2012 • Pernix Therapeutics Holdings, Inc. • Pharmaceutical preparations • Texas
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of November 13, 2012 by and among (i) Cypress Pharmaceuticals, Inc., a Mississippi corporation (the “Company”), (ii) the holders of all of the outstanding capital stock of the Company set forth on Exhibit A hereto (collectively, the “Sellers”), (iii) Pernix Therapeutics Holdings, Inc., a Maryland corporation (the “Buyer”), and (iv) for the limited purposes set forth herein that are applicable to the Sellers’ Agent, Stanton Keith Pritchard (the “Sellers’ Agent”).
